dna -脂质纳米颗粒的细胞内加工:通过图像分割的定量评估

IF 10.5 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Alessandra Cavegn , Samuel Waldner , David Wang , Jaroslaw Sedzicki , Evrim Ümit Kuzucu , Michael Zogg , Claudia Lotter , Jörg Huwyler
{"title":"dna -脂质纳米颗粒的细胞内加工:通过图像分割的定量评估","authors":"Alessandra Cavegn ,&nbsp;Samuel Waldner ,&nbsp;David Wang ,&nbsp;Jaroslaw Sedzicki ,&nbsp;Evrim Ümit Kuzucu ,&nbsp;Michael Zogg ,&nbsp;Claudia Lotter ,&nbsp;Jörg Huwyler","doi":"10.1016/j.jconrel.2025.113709","DOIUrl":null,"url":null,"abstract":"<div><div>Carriers for efficient delivery of nucleic acids, such as lipid nanoparticles (LNPs), have gained much attention for gene therapy applications. Intracellular processing of such nanocarriers is a complex mechanism comprising cellular internalization by endocytosis pathways, endosomal release into the cytosol, lysosomal degradation, and recycling. The endosomal escape rates of current formulations are considered low, and methods to reliably quantify endocytic events are not readily available. To address this shortcoming and to support the optimization of LNP formulations, the current study presents an automated live-cell imaging-based analysis method. Engineered HuH7 hepatic cell lines overexpressing fluorescent Galectin and Rab reporters together with lysosomal co-staining enabled qualitative and quantitative tracking of DNA-loaded LNPs. The use of two fluorescently labeled DNA-LNP formulations containing either SM-102 or ALC-0315 ionizable lipids revealed significant differences in endosomal escape rates and intracellular processing. Upon treatment, only subpopulations of the HuH7 target cells could be activated with respect to escape or recycling. Recycling inhibitors were therefore used to promote endosomal escape. These findings provide valuable insights into the timing and regulation of endocytic events, which will be instrumental to optimize therapeutic LNP formulations.</div></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"382 ","pages":"Article 113709"},"PeriodicalIF":10.5000,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Intracellular processing of DNA-lipid nanoparticles: A quantitative assessment by image segmentation\",\"authors\":\"Alessandra Cavegn ,&nbsp;Samuel Waldner ,&nbsp;David Wang ,&nbsp;Jaroslaw Sedzicki ,&nbsp;Evrim Ümit Kuzucu ,&nbsp;Michael Zogg ,&nbsp;Claudia Lotter ,&nbsp;Jörg Huwyler\",\"doi\":\"10.1016/j.jconrel.2025.113709\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Carriers for efficient delivery of nucleic acids, such as lipid nanoparticles (LNPs), have gained much attention for gene therapy applications. Intracellular processing of such nanocarriers is a complex mechanism comprising cellular internalization by endocytosis pathways, endosomal release into the cytosol, lysosomal degradation, and recycling. The endosomal escape rates of current formulations are considered low, and methods to reliably quantify endocytic events are not readily available. To address this shortcoming and to support the optimization of LNP formulations, the current study presents an automated live-cell imaging-based analysis method. Engineered HuH7 hepatic cell lines overexpressing fluorescent Galectin and Rab reporters together with lysosomal co-staining enabled qualitative and quantitative tracking of DNA-loaded LNPs. The use of two fluorescently labeled DNA-LNP formulations containing either SM-102 or ALC-0315 ionizable lipids revealed significant differences in endosomal escape rates and intracellular processing. Upon treatment, only subpopulations of the HuH7 target cells could be activated with respect to escape or recycling. Recycling inhibitors were therefore used to promote endosomal escape. These findings provide valuable insights into the timing and regulation of endocytic events, which will be instrumental to optimize therapeutic LNP formulations.</div></div>\",\"PeriodicalId\":15450,\"journal\":{\"name\":\"Journal of Controlled Release\",\"volume\":\"382 \",\"pages\":\"Article 113709\"},\"PeriodicalIF\":10.5000,\"publicationDate\":\"2025-04-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Controlled Release\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168365925003293\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168365925003293","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

脂质纳米颗粒(LNPs)等核酸高效递送载体在基因治疗领域的应用备受关注。这些纳米载体的细胞内加工是一个复杂的机制,包括通过内吞作用途径的细胞内化、内体释放到细胞质中、溶酶体降解和再循环。目前制剂的内体逃逸率被认为很低,而且可靠地量化内吞事件的方法也不容易获得。为了解决这一缺点并支持LNP配方的优化,本研究提出了一种基于活细胞成像的自动化分析方法。工程的HuH7肝细胞系过表达荧光凝集素和Rab报告基因,结合溶酶体共染色,可以对装载dna的LNPs进行定性和定量跟踪。使用两种荧光标记的含有SM-102或ALC-0315可电离脂质的DNA-LNP制剂显示了内体逃逸率和细胞内加工的显着差异。经过处理,只有HuH7靶细胞的亚群可以被激活以逃逸或再循环。因此,循环抑制剂用于促进内体逃逸。这些发现为内吞事件的时间和调节提供了有价值的见解,这将有助于优化治疗性LNP配方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Intracellular processing of DNA-lipid nanoparticles: A quantitative assessment by image segmentation

Intracellular processing of DNA-lipid nanoparticles: A quantitative assessment by image segmentation

Intracellular processing of DNA-lipid nanoparticles: A quantitative assessment by image segmentation
Carriers for efficient delivery of nucleic acids, such as lipid nanoparticles (LNPs), have gained much attention for gene therapy applications. Intracellular processing of such nanocarriers is a complex mechanism comprising cellular internalization by endocytosis pathways, endosomal release into the cytosol, lysosomal degradation, and recycling. The endosomal escape rates of current formulations are considered low, and methods to reliably quantify endocytic events are not readily available. To address this shortcoming and to support the optimization of LNP formulations, the current study presents an automated live-cell imaging-based analysis method. Engineered HuH7 hepatic cell lines overexpressing fluorescent Galectin and Rab reporters together with lysosomal co-staining enabled qualitative and quantitative tracking of DNA-loaded LNPs. The use of two fluorescently labeled DNA-LNP formulations containing either SM-102 or ALC-0315 ionizable lipids revealed significant differences in endosomal escape rates and intracellular processing. Upon treatment, only subpopulations of the HuH7 target cells could be activated with respect to escape or recycling. Recycling inhibitors were therefore used to promote endosomal escape. These findings provide valuable insights into the timing and regulation of endocytic events, which will be instrumental to optimize therapeutic LNP formulations.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Controlled Release
Journal of Controlled Release 医学-化学综合
CiteScore
18.50
自引率
5.60%
发文量
700
审稿时长
39 days
期刊介绍: The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信